Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Clinical trial NCT00910845 · COMPLETED
Trial details
- NCT number
- NCT00910845
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-07-01
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.